Medication info

Albos Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
SamSung Pharmaceutical Co., Ltd.
Appearance
This medicine is a round, white film-coated tablet.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201503243 · Approved 2015.05.28

This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (gastroesophageal reflux disease, ulcers, gastritis, etc.); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. The condition caused by nonsteroidal anti-inflammatory drug use usually heals within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
SamSung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (gastroesophageal reflux disease, ulcers, gastritis, etc.); prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers induced by nonsteroidal anti-inflammatory drugs.
View approved original text

This medication is used for ulcers in the stomach and duodenum, gastritis, and conditions such as Zollinger-Ellison syndrome characterized by excessive gastric acid secretion. It is also effective for the treatment of gastroesophageal reflux disease and the prevention of Mendelson's syndrome prior to anesthesia, as well as management of postoperative ulcers. It is utilized for the prevention and treatment of gastric and duodenal ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs). This drug protects the gastric mucosa and suppresses excessive gastric acid secretion, thereby improving symptoms. It is safely and effectively used for various gastric diseases.

How to take

Adult dose

Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. The condition caused by nonsteroidal anti-inflammatory drug use usually heals within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In cases of severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This drug should not be used in patients undergoing dialysis or those with kidney function impairment. Patients who have had allergic reactions to this drug or its components should not be administered this medication, and it should also be avoided in those with a history of acute porphyria. It is also safe not to administer this to patients who have undergone upper gastrointestinal surgery, pregnant women or women with a possibility of pregnancy, premature infants and newborns, and patients following a potassium-restricted diet. Patients with weakened liver function, a history of drug allergies, the elderly, and those with a past of kidney problems should exercise caution when using this medication. When taken with NSAIDs, regular check-ups are necessary, especially for the elderly or those with a history of gastric ulcers. This drug can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age experiencing new or changed dyspepsia symptoms should confirm malignancy prior to treatment. For patients with Helicobacter pylori-associated gastric or duodenal ulcers, eradication therapy should be conducted concurrently. Caution is required for patients in severe intensive care, those with hypophosphatemia, and patients with difficulty swallowing. Rarely, serious allergic reactions such as anaphylactic shock may occur with this drug, so if symptoms occur, administration should stop immediately, and appropriate treatment should be secured. Hypersensitive reactions may include rash, urticaria, angioedema, fever, and bronchospasm, and dosing should be stopped if such symptoms appear. Hematologic abnormalities such as reversible leukopenia and thrombocytopenia may occur rarely, and if symptoms like fatigue, bleeding, or fever arise, immediate testing and, if necessary, discontinuation of medication are required. Transient liver function impairment may occur, and if symptoms of jaundice or hepatitis appear, drug use should be stopped immediately. Cardiovascular abnormalities such as arrhythmias or vasculitis have also been reported rarely, so caution is warranted. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain; however, changes in stool color do not require specific treatment. In the elderly and severe cases, neurological symptoms such as dizziness, drowsiness, confusion, insomnia, and headaches may occur, so consultation with a physician should occur immediately if abnormal symptoms arise. Endocrine disorders such as gynecomastia and erectile dysfunction have also been reported rarely. Musculoskeletal symptoms such as myalgia, arthralgia, and rhabdomyolysis may also occur rarely, so caution is needed for severe muscle pain or weakness. Cutaneous abnormalities such as skin rash or hair loss may occur rarely. It is advisable not to take this medication for an extended period, and regular blood tests and liver and kidney function checks should be performed during treatment. Elderly patients or those with chronic illnesses may have an increased risk of pneumonia, so they should be mindful of infection symptoms. If dizziness or drowsiness is felt while taking this drug, driving or operating hazardous machinery should be avoided. This medication may affect the absorption or metabolism of other drugs, so caution is needed when taking it with other medications, and it should be communicated to a physician or pharmacist. Particularly, interactions may occur with some antibiotics or anticonvulsants and anticoagulants, necessitating spacing or dosage adjustments when used together. It is safest for pregnant or breastfeeding women not to use this medication, and its safety in children has not been established, so use is not recommended. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be required, and blood dialysis may be performed if necessary. This drug may reduce gastric acid secretion and promote bacterial growth in the stomach, so regular check-ups including ophthalmologic examinations are necessary with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 50 more
  • thrombocytopenia
  • increased serum creatinine
  • increased serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired hemolytic anemia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sense
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • tics
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • tongue discoloration
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure, and it is best kept at room temperature between 1 and 30 degrees Celsius. Doing so will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

This medicine is a round, white film-coated tablet.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.